SuperworthAprea Therapeutics shares outstanding APRE
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 53.5M
- On a year earlier
- +779.2%
- more shares
Aprea Therapeutics had 53.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 779.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 7.7M | +29% |
| FY2024 | 6M | +59% |
| FY2023 | 3.7M | +41% |
| FY2022 | 2.6M | +146% |
| FY2021 | 1.1M | +2% |
| FY2020 | 1.1M | +1735% |
| FY2018 | 57.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 53.5M | +779% | |
| Q1 FY26 | 14.7M | +145% | |
| Q4 FY25 | 7.7M | +29% | |
| Q3 FY25 | 6.4M | +7% | |
| Q2 FY25 | 6.1M | +2% | |
| Q1 FY25 | 6M | +43% | |
| Q4 FY24 | 6M | +59% | |
| Q3 FY24 | 5.9M | +59% | |
| Q2 FY24 | 5.9M | +59% | |
| Q1 FY24 | 4.2M | +29% | |
| Q4 FY23 | 3.7M | +41% | |
| Q3 FY23 | 3.7M | +116% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aprea Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.